SCHEMBL22155409

SCHEMBL22155409

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4cc6c(cc54)sc4ccc5ccccc5c46)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SOS1 Q07889 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
MAPT P10636 1/20 0.32
NQO2 P16083 2/20 0.32
NQO1 P15559 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082183 0.92 KDM4E (0.34) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL17945306 0.92 CHEK1 (0.37) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL22155539 0.92 CYP1A1 (0.35) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL22155424 0.91 NQO2 (0.33) MEN1KMT2ASOS1ALDH1A1HPGD
SCHEMBL19082184 0.91 KDM4E (0.33) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL17944345 0.90 KDM4E (0.36) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL19082175 0.89 CYP1A1 (0.35) KDM4EMEN1KMT2ASOS1ALDH1A1
SCHEMBL22260292 0.87 CYP1A1 (0.35) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL22155455 0.87 SOS1 (0.36) MEN1KMT2ASOS1ALDH1A1HPGD
SCHEMBL19082320 0.87 NQO2 (0.33) KDM4EMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 KDM4E 2771/4885MEN1 1091/4885KMT2A 3249/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 KDM4E 2771/4885MEN1 1091/4885KMT2A 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.